Grants and Contracts Details
Our long-term objective is to understand mechanisms of lesion bypass in eukaryotes. Lesion bypass is an important cellular response to unrepaired DNA damage during replication. Error-prone lesion bypass is the major mechanism of DNA damage-induced mutagenesis and represents a major factor in carcinogenesis. In eukaryotes, mechanisms of lesion bypass are poorly understood. Lesion bypass requires a specialized DNA polymerase (Pol). However, it is not clear which polymerases are involved in lesion bypass in cells. We hypothesize that (a) Polzeta, Poln, Polkappa, and Rev1 are involved in DNA synthesis opposite the lesion in vivo; and (b) efficient bypass of some lesions in cells requires nucleotide incorporation opposite the lesion by one polymerase and subsequent extension DNA synthesis by Polzeta. Polzeta , Poln, Polkappa, and Rev1 are able to incorporate nucleotides opposite several DNA lesions in vitro. In this proposal, the role of these polymerases in lesion bypass in vivo and their relationships to damage-induced mutagenesis will be studied. Our specific aims are: (1) to study the function of Polzeta in DNA lesion bypass; (2) to determine the role of Rev1 in DNA lesion bypass; (3) to investigate cellular function of Poln in response to chemical induced DNA lesions; and (4) to examine the in vivo role of Polkappa in DNA lesion bypass and its relationship to damage-induced metagenesis. To accomplish the aims, in vivo genetic experiments will be performed using the yeasts S. cerevisiae and S. pombe as eukaryotic model organisms. In vivo mutagenesis experiments will be performed in yeast strains proficient or deficient in polzeta, Poln, Po1kappa, and Rev1 activities, using-stranded plasmid vector containing a site-specific DNA damage, including abasic site and four stereoiomeric anti-benzo[a]pyrene-N2-dG adducts in several sequence contexts. Genetic results will be interpreted with the help of in vitro biochemical experiments. The proposed studies should significantly advance our understanding of mechanisms of lesion bypass and damage-induced mutagenesis in eukaryotic cells.
|Effective start/end date||4/1/02 → 3/31/05|
- National Cancer Institute
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.